Educational research on US and Indian equities, ETFs, mutual funds and crypto, with screeners and a free investing academy.
All data is for educational purposes only and should not be considered investment advice.
Equiscale is operated by Syntellia LLC, a Delaware limited liability company.
© 2026 Syntellia LLC. All rights reserved.
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
Rule-based from financial data. Not advice.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 5 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $5.9B | $-369M | $-391M | $-149M | -308.8% | -2.1% | 50.4% |
| 2024 | $6.1B | $-218M | $-260M | $-99M | -55.2% | 40.4% | -0.9% |
| 2023 | $4.3B | $-168M | $-263M | $-187M | -39.7% | 80.7% | 146.4% |
| 2022 | $2.4B | $-72M | $-107M | $-163M | -10.2% | - | - |
| 2021 | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2025 |
|---|---|
| Total Revenue | 5,932.58 |
| Operating Revenue | 5,921.34 |
| Cost Of Revenue | 6,092.60 |
| Gross Profit | -160.02 |
| Operating Expense | 267.13 |
| Selling General And Administration | 238.54 |
| Total Expenses | 6,359.73 |
| Operating Income | -427.15 |
| Total Operating Income As Reported | -463.24 |
| EBITDA | -368.86 |
| Normalized EBITDA | -332.78 |
| EBIT | -397.46 |
| Interest Expense | 6.64 |
| Net Interest Income | -6.64 |
| Other Non Operating Income Expenses | 67.62 |
| Other Income Expense | 29.70 |
| Interest Expense Non Operating | 6.64 |
| Net Non Operating Interest Income Expense | -6.64 |
| Pretax Income | -404.10 |
| Tax Provision | 1.25 |
| Tax Rate For Calcs | 0 |
| Tax Effect Of Unusual Items | 0 |
| Net Income Continuous Operations | -405.35 |
| Net Income From Continuing And Discontinued Operation | -391.35 |
| Net Income From Continuing Operation Net Minority Interest | -405.35 |
| Net Income | -391.35 |
| Net Income Common Stockholders | -391.35 |
| Net Income Including Noncontrolling Interests | -391.35 |
| Normalized Income | -369.26 |
| Diluted NI Availto Com Stockholders | -391.35 |
| Basic Average Shares | 16.56 |
| Diluted Average Shares | 16.56 |
| Reconciled Depreciation | 28.59 |
| Reconciled Cost Of Revenue | 6,092.60 |
| Total Unusual Items | -36.08 |
| Total Unusual Items Excluding Goodwill | -36.08 |
| Minority Interests | 0 |
| Net Income Discontinuous Operations | 14 |
| Special Income Charges | -36.08 |
| Other Special Charges | - |
| Write Off | 36.08 |
| Depreciation Amortization Depletion Income Statement | 28.59 |
| Depreciation And Amortization In Income Statement | 28.59 |
| General And Administrative Expense | 238.54 |
| Other Gand A | 238.54 |
| Earnings From Equity Interest | -1.84 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| agilon health, inc.this co. | AGL | $1.6B | - | 12.54 | -308.8% | - |
| Fortrea Holdings Inc. | FTRE | $1.6B | - | 2.90 | -175.0% | - |
| Capricor Therapeutics, Inc. | CAPR | $1.6B | -15.41 | 5.29 | -34.4% | -13.44 |
| Tyra Biosciences, Inc. | TYRA | $1.6B | -13.48 | 6.24 | -46.3% | -11.68 |
| Syndax Pharmaceuticals, Inc. | SNDX | $1.6B |
| - |
| - |
| - |
| - |
| - |
| -5.59 |
| 24.71 |
| -441.6% |
| -7.18 |
| Amylyx Pharmaceuticals, Inc. | AMLX | $1.6B | -10.99 | 5.21 | -47.4% | -8.97 |
| Nurix Therapeutics, Inc. | NRIX | $1.6B | - | 2.93 | -49.1% | - |
| Sonida Senior Living, Inc. | SNDA | $1.6B | -22.19 | -142770.48 | 643445.5% | 96.78 |
| Vir Biotechnology, Inc. | VIR | $1.5B | - | 2.02 | -57.2% | - |
| Peer Median | - | -13.48 | 4.07 | -48.3% | -8.97 | |